CompuMed
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CompuMed generated cash of $520,476, which is less than the previous year. Cash used in financing activities reached the amount of -$869,821 last year. Net change in cash is therefore -$719,720.
Cash Flow
| 2017 | 175.43K | -57.17K | 8.66K |
|---|---|---|---|
| 2019 | 953.40K | -531.76K | 462.95K |
| 2020 | 1.06M | -795.24K | 458.13K |
| 2021 | 1.41M | -881.93K | -215.26K |
| 2022 | 735.58K | -908.84K | -240.46K |
| 2023 | 520.47K | -370.37K | -869.82K |
CMPD Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 1.79M | 2.21M | 1.89M | 1.18M | 300.19K | 125.63K |
Operating activities | ||||||
Net income | -32.60K | 501.85K | 1.06M | 338.43K | 973.78K | 84.94K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 678.19K | 568.26K | 352.62K | 234.82K | 273.03K | 75.11K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 158.62K | -202.00K | -62.18K | 30.49K | -161.14K | -66.02K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -7.06K | -48.59K | 281.41K | 177.55K | -109.52K | 90.56K |
Cash generated by operating activities | 520.47K | 735.58K | 1.41M | 1.06M | 953.40K | 175.43K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -370.37K | -908.84K | -881.93K | -795.24K | -531.76K | -57.17K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -370.37K | -908.84K | -881.93K | -795.24K | -531.76K | -57.17K |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | -87K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -724.33K | -13.94K | 0 | -40.55K | 0 | 0 |
Repayments of term debt | -145.48K | -226.51K | -215.26K | -585.68K | 0 | 0 |
Cash used in financing activities | -869.82K | -240.46K | -215.26K | 458.13K | 462.95K | 8.66K |
Net Change In Cash | -719.72K | -413.72K | 322.21K | 705.63K | 884.60K | 126.92K |
Cash at end of period | 1.07M | 1.79M | 2.21M | 1.89M | 1.18M | 252.55K |